Successful Treatment of Relapsed Acquired Amegakaryocytic Thrombocytopenia with Repeat Cyclosporine / 대한내과학회지
Korean Journal of Medicine
;
: 258-261, 2016.
Article
in English
| WPRIM
| ID: wpr-36016
ABSTRACT
Acquired amegakaryocytic thrombocytopenia (AAMT) is an unusual disease characterized by severe thrombocytopenia resulting from a marked decrease in bone marrow megakaryocytes. Various pathogenic mechanisms have been suggested, and several treatments have been tried, with varying outcomes. In some case reports, cyclosporine and anti-thymocyte globulin have had good clinical results in the treat of AAMT. There are few reports on the treatment of relapsed AAMT with cyclosporine. We report a patient with relapsed AAMT who was treated successfully with an additional course of cyclosporine. The initial remission was achieved with cyclosporine 4 years earlier and a second remission was induced by cyclosporine. Cyclosporine may be effective for relapsed AAMT that previously responded to cyclosporine.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Thrombocytopenia
/
Bone Marrow
/
Megakaryocytes
/
Cyclosporine
/
Antilymphocyte Serum
Limits:
Humans
Language:
English
Journal:
Korean Journal of Medicine
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS